At the news
? NEUTRALIMPACT 2/10 8-K filed Aug 19, 2026 at 07:30 ET
MediciNova entered into new executive employment agreements with CEO Yuichi Iwaki and CMO Kazuko Matsuda, formalizing base salaries ($690,246 for Iwaki, $540,143 for Matsuda), target bonuses, and severance terms including change-in-control protections. This is a routine compensation and retention filing with no departure, resignation, or financial results, it does not signal any operational or strategic change.
- CEO Yuichi Iwaki's annual base salary set at $690,246 with target bonus of 55% of base salary
- CMO Kazuko Matsuda's annual base salary set at $540,143 with target bonus of 40% of base salary
- Both executives receive 12-month salary severance on involuntary termination without cause (no change in control)
- On change-in-control termination: Iwaki gets 24 months salary + 24 months target bonus; Matsuda gets 18 months salary + 18 months target bonus
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access